Rafael Amado's Net Worth

$4.26 Million

Estimate Recalculated Nov 7, 2024 11:53AM EST

Who is Rafael Amado?

Rafael Amado has an estimated net worth of $4.26 Million. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., Adaptimmune Therapeutics PLC, Zai Lab Ltd, and Poseida Therapeutics, Inc..

SEC CIK

Rafael Amado's CIK is 0001662119

Past Insider Trading and Trends

2023 was Rafael Amado's most active year for acquiring shares with 6 total transactions. Rafael Amado's most active month to acquire stocks was the month of December. 2022 was Rafael Amado's most active year for disposing of shares, totalling 7 transactions. Rafael Amado's most active month to dispose stocks was the month of September. 2024 saw Rafael Amado paying a total of $85,716.90 for 250,624 shares, this is the most they've acquired in one year. In 2020 Rafael Amado cashed out on 26,290 shares for a total of $1,006,176.22, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Allogene Therapeutics, Inc. (ALLO) Snapshot price: $2.39

EVP R&D

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2.01%
10.66K
$11.83
-$100,099.50
541.95K
Oct 7
Form 4
-1.66%
-8.97K
$11.06
-$99,201.33
531.29K
Oct 3
Form 4
-0.37%
-2.00K
$11.97
-$23,940.00
540.26K
Scheduled
Aug 2
Form 4
-0.37%
-2.00K
$11.44
-$22,880.00
542.26K
Scheduled
Jul 5
Form 4
-0.37%
-2.00K
$11.18
-$22,360.00
544.26K
Scheduled
Jun 21
Form 4
-2.06%
-11.50K
$7.40
-$85,091.95
546.26K
May 19
Form 4
+74.15%
237.36K
—
—
557.48K
Mar 23
Form 4
-1.59%
-5.17K
$7.71
-$39,847.82
320.12K
Mar 15
Form 4
-3.43%
-11.51K
$24.35
-$280,185.09
323.93K
Oct 1
Form 4
+148.65%
200.53K
—
—
335.44K
May 18
Form 4
+22.60%
24.87K
—
—
134.9K
Mar 26
Form 4
-2.48%
-2.80K
$38.05
-$106,470.62
110.03K
Mar 15
Form 4
-12.90%
-16.54K
$39.40
-$651,514.51
111.68K
Scheduled
Oct 7
Form 4
-7.07%
-9.75K
$36.37
-$354,661.71
128.22K
Oct 1
Form 4
+29.29%
30.8K
—
—
135.96K
Mar 18
Form 4
∞
105.16K
—
—
105.16K
Sep 3
Form 3
—
0
—
—
0
No matching records found

Adaptimmune Therapeutics PLC (ADAP) Snapshot price: $1.09

President, R&D

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-39.05%
-11.04K
$2.06
-$22,748.58
17.24K
Aug 6
Form 4
-37.84%
-3.03K
$5.37
-$16,258.54
4.97K
Jan 14
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Aug 6
Form 4
—
0
—
—
0
Jan 12
Form 4
—
0
—
—
0
Jan 13
Form 4
—
0
—
—
0
Jan 18
Form 3
—
0
—
—
0
No matching records found

Zai Lab Ltd (ZLAB) Snapshot price: $19.85

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-13.24%
-3.12K
$16.20
-$50,463.00
20.42K
Aug 12
Form 4
+17.12%
3.44K
$15.79
$55,123.20
23.53K
Apr 3 - Apr 4
Form 4
—
0
—
—
0
Apr 1
Form 4
-11.24%
-2.54K
$18.86
-$47,979.84
20.09K
Mar 15
Form 4
∞
22.64K
$26.30
-$509,169.45
22.64K
Dec 29 - Jan 2
Form 4
—
0
—
—
0
Apr 3
Form 4
∞
126K
—
—
126K
Dec 30
Form 3
—
0
—
—
0
No matching records found

Poseida Therapeutics, Inc. (PSTX) Snapshot price: $2.74

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+50.00%
19.65K
—
—
58.95K
Jun 17
Form 4
∞
39.3K
—
—
39.3K
May 1
Form 3
—
0
—
—
0
No matching records found